filgotinib
Selected indexed studies
- Filgotinib. (, 2006) [PMID:38652795]
- Filgotinib: A Clinical Pharmacology Review. (Clin Pharmacokinet, 2022) [PMID:35637376]
- Filgotinib: First Approval. (Drugs, 2020) [PMID:33237566]
_Worker-drafted node — pending editorial review._
Connections
filgotinib is a side effect of
Sources
- Filgotinib. (2006) pubmed
- Filgotinib: A Clinical Pharmacology Review. (2022) pubmed
- Filgotinib: First Approval. (2020) pubmed
- Filgotinib in rheumatoid arthritis. (2023) pubmed
- JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib. (2021) pubmed
- Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. (2021) pubmed
- Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial. (2019) pubmed
- Filgotinib for moderately to severely active ulcerative colitis. (2022) pubmed
- Filgotinib in Rheumatoid Arthritis: A Profile of Its Use. (2021) pubmed
- Evaluating filgotinib for the treatment of rheumatoid arthritis. (2021) pubmed